Predictors of Residual Disease in Repeat Excisions for Lumpectomies with Margins Less Than 0.1 cm

Surgery in recurrent epithelial ovarian

Surgery in recurrent epithelial ovarian cancer: Benefits on Survival for patients with residual disease of 0.1–1 cm after secondary cytoreduction

✍ Wen-Juan Tian; Rong Jiang; Xi Cheng; Jie Tang; Yan Xing; Rong-Yu Zang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

## Abstract ## Aims Recent retrospective trials stated that a benefit of surgery for recurrent ovarian cancer may be limited to patients in whom a complete cytoreduction (R0) could be achieved. Most of them pointed out there was no difference in survival between residual disease of 0.1–1 cm (R1) a